retatrutide ly3437943 triple agonist glp-1 gip glucagon mechanism LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism retatrutide mechanism triple agonist glp-1

This might increase the change of bruising and bleeding

If diarrhea occurs, ensure adequate hydration and electrolyte replacement

CagriSema combined cagrilintide with semaglutide (a single-receptor GLP-1 drug)

And for the production of neurotransmitters and neuromodulators, things like dopamine and serotonin

Gunel, Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide casecontrol study in New Caledonia, Cancer Causes Control , vol

NINA MOINI: When it comes to GLP-1s, have you seen in your experience as a doctor or some of perhaps the trouble around the medication or downsides that might need more attention